Botuo Biotech said at the 2026 semi-annual performance briefing held on September 7 that the company continues to increase R&D investment in the main business, continuously promote innovative product development and transformation of achievements, and enhance the overall competitiveness of products. At the same time, the company will take the opportunity to actively open up a new growth track through mergers and acquisitions in the medical and health sector.

Zhitongcaijing · 3d ago
Botuo Biotech said at the 2026 semi-annual performance briefing held on September 7 that the company continues to increase R&D investment in the main business, continuously promote innovative product development and transformation of achievements, and enhance the overall competitiveness of products. At the same time, the company will take the opportunity to actively open up a new growth track through mergers and acquisitions in the medical and health sector.